112 related articles for article (PubMed ID: 28557540)
21. [Prognosis analysis of 247 cases of gastrointestinal stromal tumor].
Ning L; Zhang DF; Zhou YB; Jiao XL; Cao SG
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):247-50. PubMed ID: 23536345
[TBL] [Abstract][Full Text] [Related]
22. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
Casali PG; Zalcberg J; Le Cesne A; Reichardt P; Blay JY; Lindner LH; Judson IR; Schöffski P; Leyvraz S; Italiano A; Grünwald V; Pousa AL; Kotasek D; Sleijfer S; Kerst JM; Rutkowski P; Fumagalli E; Hogendoorn P; Litière S; Marreaud S; van der Graaf W; Gronchi A; Verweij J;
J Clin Oncol; 2017 May; 35(15):1713-1720. PubMed ID: 28362562
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A
Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
[TBL] [Abstract][Full Text] [Related]
25. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST).
Kramer K; Knippschild U; Mayer B; Bögelspacher K; Spatz H; Henne-Bruns D; Agaimy A; Schwab M; Schmieder M
BMC Cancer; 2015 Feb; 15():57. PubMed ID: 25886494
[TBL] [Abstract][Full Text] [Related]
26. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
[TBL] [Abstract][Full Text] [Related]
27. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
28. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.
Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG
World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
30. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.
Cubukcu E; Olmez OF; Avci N; Canhoroz M; Kurt E; Kanat O; Evrensel T; Manavoglu O
J BUON; 2012; 17(3):517-21. PubMed ID: 23033292
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
[TBL] [Abstract][Full Text] [Related]
32. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
[TBL] [Abstract][Full Text] [Related]
33. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
[TBL] [Abstract][Full Text] [Related]
34. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
Hsu CC; Wu CE; Chen JS; Tseng JH; Chiang KC; Liu YY; Tsai CY; Cheng CT; Chen TW; Jan YY; Yeh TS; Chen YY; Yeh CN
Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
[TBL] [Abstract][Full Text] [Related]
35. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS).
Rubió-Casadevall J; Martinez-Trufero J; Garcia-Albeniz X; Calabuig S; Lopez-Pousa A; Del Muro JG; Fra J; Redondo A; Lainez N; Poveda A; Valverde C; De Juan A; Sevilla I; Casado A; Andres R; Cruz J; Martin-Broto J; Maurel J;
Ann Surg Oncol; 2015 Sep; 22(9):2948-57. PubMed ID: 25608769
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
[TBL] [Abstract][Full Text] [Related]
37. A Population-Based Study of the Incidence and Survival of Anorectal Gastrointestinal Stromal Tumor.
Liu Z; Wu S; Gou S; Li Y; Wu H; Li Y
Med Sci Monit; 2019 Jul; 25():5408-5417. PubMed ID: 31326976
[TBL] [Abstract][Full Text] [Related]
38. The impact of additional malignancies in patients diagnosed with gastrointestinal stromal tumors.
Smith MJ; Smith HG; Mahar AL; Law C; Ko YJ
Int J Cancer; 2016 Oct; 139(8):1744-51. PubMed ID: 27299364
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
[TBL] [Abstract][Full Text] [Related]
40. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
